+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Phishing Simulators - Global Stategic Business Report

  • PDF Icon

    Report

  • 291 Pages
  • June 2025
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 6094544
The global market for Phishing Simulators was estimated at US$66.4 Million in 2024 and is projected to reach US$92.7 Million by 2030, growing at a CAGR of 5.7% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Phishing Simulators market.

Global Phishing Simulators Market - Key Trends & Drivers Summarized

Why Are Phishing Simulators Becoming a Non-Negotiable Component of Cybersecurity Training?

The escalating sophistication of social engineering attacks has made phishing the most prevalent threat vector across enterprises globally. Phishing simulators have emerged as a critical frontline defense, enabling organizations to proactively test employee vigilance and build cyber-resilience through realistic attack emulation. These platforms replicate real-world phishing attempts via email, SMS, or social media to evaluate user behavior, identify risk-prone personnel, and tailor security awareness training accordingly.

With remote and hybrid work models expanding the digital attack surface, the importance of phishing simulation tools has surged across sectors such as finance, healthcare, retail, and government. Security teams are no longer relying solely on static awareness sessions; instead, they are deploying continuous simulation-based training that mimics evolving threats, including credential harvesting, ransomware lures, spear-phishing, and business email compromise. This shift is embedding phishing simulators into broader security frameworks governed by Zero Trust and compliance mandates such as GDPR, HIPAA, and NIST.

How Are AI, Gamification, and Risk Scoring Redefining Platform Capabilities and Engagement?

Modern phishing simulators are being enhanced with AI-driven threat intelligence engines that generate dynamic, context-specific attack templates mimicking trending cyberattack methods. These templates reflect region-specific scams, language nuances, and impersonation tactics dramatically improving simulation realism and employee preparedness. AI is also helping to personalize difficulty levels and analyze behavioral trends to deliver granular insights into susceptibility patterns across departments, roles, and geographic locations.

Gamification elements such as badges, leaderboards, and interactive learning modules are being integrated into simulation workflows to improve engagement and long-term behavior change. Progressive training paths, adaptive content delivery, and real-time feedback mechanisms are transforming phishing simulators into continuous learning ecosystems. Additionally, advanced risk scoring frameworks now allow CISOs and compliance teams to quantify user-level risk, compare organizational benchmarks, and generate audit-ready reports that meet regulatory obligations.

Why Are MSPs, Compliance Pressures, and Incident Response Strategies Expanding Simulator Adoption?

Managed Security Service Providers (MSSPs) and Managed Service Providers (MSPs) are increasingly incorporating phishing simulators into bundled cybersecurity offerings to cater to SMEs and mid-market clients. These integrations provide turnkey simulation and training solutions with centralized dashboards, API-enabled provisioning, and cross-platform compatibility. The demand for scalable, multi-tenant simulation solutions is rising in sectors with limited internal cybersecurity resources but high exposure to phishing attacks.

Meanwhile, regulators and insurers are tightening expectations around security awareness and user training. Organizations are now required to demonstrate proactive anti-phishing strategies as part of cyber insurance underwriting and ISO 27001 audits. Phishing simulators not only help meet these compliance requirements but also reinforce incident response readiness by mapping simulated attack results to detection and mitigation workflows. As phishing remains the most common root cause of data breaches, integrating simulation into incident response playbooks is becoming a best practice across mature security environments.

What's Driving the Global Growth of the Phishing Simulators Market?

The growth in the phishing simulators market is driven by several factors including the rising frequency of socially engineered cyberattacks, regulatory compliance requirements, and the growing emphasis on human-centric cybersecurity strategies. A key growth driver is the enterprise realization that technical controls alone are insufficient, and that continuous user awareness is essential to close the last mile in security defenses.

Organizations across all verticals are investing in phishing simulation platforms to build cyber-resilient cultures, quantify employee risk, and strengthen overall security posture. As attack sophistication increases and digital workspaces become more distributed, phishing simulators are evolving into mission-critical tools for cyber risk management. The intersection of AI, behavioral analytics, compliance integration, and user-centric design ensures that the global phishing simulator market will continue to grow rapidly especially as organizations shift from reactive to preventive cybersecurity models.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Cloud segment, which is expected to reach US$66.4 Million by 2030 with a CAGR of a 6.6%. The On-Premise segment is also set to grow at 3.7% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $18.1 Million in 2024, and China, forecasted to grow at an impressive 9.2% CAGR to reach $18.9 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Phishing Simulators Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Phishing Simulators Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Phishing Simulators Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as Barracuda Networks, CanIPhish, Cofense, ESET, and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 48 companies featured in this Phishing Simulators market report include:

  • Barracuda Networks
  • CanIPhish
  • Cofense
  • ESET
  • Fortinet
  • Hoxhunt
  • Infosec
  • IRONSCALES
  • Keepnet Labs
  • KnowBe4
  • MetaCompliance
  • Microsoft
  • Phished
  • PhishingBox
  • Proofpoint
  • Sophos
  • Terranova Security
  • TitanHQ
  • usecure
  • ZeroFox

This edition integrates the latest global trade and economic shifts as of June 2025 into comprehensive market analysis. Key updates include:

  • Tariff and Trade Impact: Insights into global tariff negotiations across 180+ countries, with analysis of supply chain turbulence, sourcing disruptions, and geographic realignment. Special focus on 2025 as a pivotal year for trade tensions, including updated perspectives on the Trump-era tariffs.
  • Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization. Includes segmentation by product, technology, type, material, distribution channel, application, and end-use, with historical analysis since 2015.
  • Strategic Market Dynamics: Evaluation of revised market prospects, regional outlooks, and key economic indicators such as population and urbanization trends.
  • Innovation & Technology Trends: Latest developments in product and process innovation, emerging technologies, and key industry drivers shaping the competitive landscape.
  • Competitive Intelligence: Updated global market share estimates for 2025, competitive positioning of major players (Strong/Active/Niche/Trivial), and refined focus on leading global brands and core players.
  • Expert Insight & Commentary: Strategic analysis from economists, trade experts, and domain specialists to contextualize market shifts and identify emerging opportunities.
  • Complimentary Update: Buyers receive a free July 2025 update with finalized tariff impacts, new trade agreement effects, revised projections, and expanded country-level coverage.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Interstitial Cystitis Drugs - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Diagnosis Rates of Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) Propel Demand for Pharmacological Treatment Options
  • Growing Awareness and Early Detection Campaigns Support Expansion of the Interstitial Cystitis Therapeutics Market
  • Limited Availability of Curative Therapies Strengthens the Business Case for Chronic Symptom Management Drugs
  • Increasing Use of Multimodal Treatment Approaches Drives Demand for Combination Drug Regimens in IC Management
  • FDA Approvals and Fast Track Designations for New IC Drugs Encourage Pipeline Innovation and Investment
  • Rising Patient Preference for Non-Invasive Oral Therapies Sustains Demand for Oral Pentosan Polysulfate Sodium and Antihistamines
  • Emergence of Intravesical Drug Delivery Systems Enhances Bioavailability and Targeted Relief for Bladder Pain
  • Focus on Neuroinflammatory and Immune-Driven Etiologies Drives Interest in Immunomodulators and Mast Cell Stabilizers
  • Increased Off-Label Use of Antidepressants and Anticonvulsants Highlights Opportunities for Drug Repositioning
  • Clinical Research on Alternative Pathways, Including TRP Channels and NGF Inhibitors, Fuels Innovation in IC Therapies
  • Rising Incidence of Comorbid Chronic Pelvic Pain Conditions Expands Therapeutic Application of IC Drugs
4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Interstitial Cystitis Drugs Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Interstitial Cystitis Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Interstitial Cystitis Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Interstitial Cystitis Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Non-Steroidal Anti-inflammatory Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Non-Steroidal Anti-inflammatory Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Non-Steroidal Anti-inflammatory Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Tricyclic Antidepressants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Tricyclic Antidepressants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Tricyclic Antidepressants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Pentosan Polysulfate Sodium by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Pentosan Polysulfate Sodium by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Pentosan Polysulfate Sodium by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Dimethyl Sulfoxide by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Dimethyl Sulfoxide by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Dimethyl Sulfoxide by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Other Drug Classes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Other Drug Classes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Other Drug Classes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Online Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Non-Ulcerative by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Non-Ulcerative by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Non-Ulcerative by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Ulcerative by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Ulcerative by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Ulcerative by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Oral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Oral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Oral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Intravesical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Intravesical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Intravesical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Interstitial Cystitis Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
CANADA
JAPAN
  • Interstitial Cystitis Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
CHINA
  • Interstitial Cystitis Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
EUROPE
  • Interstitial Cystitis Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
FRANCE
  • Interstitial Cystitis Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
GERMANY
  • Interstitial Cystitis Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
ITALY
UNITED KINGDOM
  • Interstitial Cystitis Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
SPAINRUSSIAREST OF EUROPE
ASIA-PACIFIC
  • Interstitial Cystitis Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
AUSTRALIA
  • Interstitial Cystitis Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
INDIA
  • Interstitial Cystitis Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Interstitial Cystitis Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Interstitial Cystitis Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Interstitial Cystitis Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Barracuda Networks
  • CanIPhish
  • Cofense
  • ESET
  • Fortinet
  • Hoxhunt
  • Infosec
  • IRONSCALES
  • Keepnet Labs
  • KnowBe4
  • MetaCompliance
  • Microsoft
  • Phished
  • PhishingBox
  • Proofpoint
  • Sophos
  • Terranova Security
  • TitanHQ
  • usecure
  • ZeroFox

Table Information